BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2846826)

  • 1. Neuromuscular transmission changes associated with tolerance development after chronic exposure to diisopropylfluorophosphate.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1988 Nov; 247(2):635-9. PubMed ID: 2846826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effects of paraoxon on transmitter release and the synaptic contribution to tolerance.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1986 Jun; 237(3):689-94. PubMed ID: 3712275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute alterations in murine neuromuscular transmission following exposure to a nonparalytic dose of dithiobiuret.
    Spitsbergen JM; Atchison WD
    Toxicol Appl Pharmacol; 1990 Jan; 102(1):68-79. PubMed ID: 2153319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of diisopropylfluorophosphate (DFP) toxicity and tolerance in rats.
    Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):399-418. PubMed ID: 6856947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in presynaptic release of acetylcholine during development of tolerance to the anticholinesterase, DFP.
    Russell RW; Booth RA; Jenden DJ; Roch M; Rice KM
    J Neurochem; 1985 Jul; 45(1):293-9. PubMed ID: 3998726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental tests of hypotheses about neurochemical mechanisms underlying behavioral tolerance to the anticholinesterase, diisopropyl fluorophosphate.
    Russell RW; Overstreet DH; Cotman CW; Carson VG; Churchill L; Dalglish FW; Vasquez BJ
    J Pharmacol Exp Ther; 1975 Jan; 192(1):73-85. PubMed ID: 164530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.
    Melchers BP; van Helden HP
    Pharmacol Biochem Behav; 1990 Feb; 35(2):321-5. PubMed ID: 2157228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of acute behavioral toxicity of low doses of diisopropylfluorophosphate (DFP) in rats.
    Nieminen SA; Sirkka U; Lecklin A; Heikkinen O; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):617-23. PubMed ID: 1787768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of heavy metals on synaptic transmission: a review.
    Cooper GP; Manalis RS
    Neurotoxicology; 1983; 4(4):69-83. PubMed ID: 6322059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydration affects synaptic transmission at flexor muscle in acute lead-treated mice.
    Al Shuaib WB; Fahim MA; Davidson N
    Cell Mol Biol (Noisy-le-grand); 1999 Jun; 45(4):407-11. PubMed ID: 10432187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipsogenic effects of intra and extracellular thirst stimuli before and after chronic DFP treatment.
    Overstreet DH; Schiller GD; Biggins JG; Crane G
    Psychopharmacol Commun; 1975; 1(2):157-64. PubMed ID: 1223996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DFP on unit activity in rat superior colliculus.
    Cheney PD; Kasser RJ; Holsapple J
    Neurotoxicology; 1987; 8(4):593-605. PubMed ID: 3441320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus.
    Williamson AM; Sarvey JM
    J Pharmacol Exp Ther; 1985 Nov; 235(2):448-55. PubMed ID: 4057081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of testosterone on neuromuscular transmission in hormone sensitive mammalian skeletal muscles.
    Souccar C; Lapa AJ; do Valle JR
    Muscle Nerve; 1982 Mar; 5(3):232-7. PubMed ID: 6283341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.